# KOOYO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kooyo

- Industry: Food
- Headquarters: Hangzhou, China
- Latest round: Series B (Aug 18, 2021)
- Investors on record: 2

## About

Founded in 2020 and based in Hangzhou, China, KOOYO is a food manufacture company that focuses on health care products. It has obtained 15 Research and Development patents. The team members of the company came from Harvard Medical School, Yale University, University of California Food School, Zhejiang University and other international institutions. Its operation team members used to work in Procter & Gamble, Baidu and other companies. In August 2021, it closed series B funding from new investors Dalton Venture and Meridian Capital China.

The company's main product category is healthcare product. It owns the core brand series THE ONE, and extends its product lines into Parents, Children, and Couples. The main component of the one is nicotinamide mononucleotide. The main target consumers of the company are people aged 25 to 40 who face problems such as high work pressure, and poor sleep.

## Funding rounds

- Series B, Aug 18, 2021 — Meridian Capital, Dalton Venture

## Investors

- Meridian Capital — Series B
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series B